Autoimmunity in context of exposure to SARS-Cov2 virus

1 Chen Y, Xu Z, Wang P, et al. New-onset autoimmune phenomena post-COVID-19 vaccination. Immunology. 2022;165(4): 386-401. doi:10.1111/imm.13443 Search in Google Scholar

2 Chang R, Yen-Ting Chen T, Wang SI, Hung YM, Chen HY, Wei CJ. Risk of autoimmune diseases in patients with COVID-19: A retrospective cohort study. EClinicalMedicine. 2023;56:101783. doi:10.1016/j.eclinm.2022.101783 Search in Google Scholar

3 Mouzarou A, Ioannou M, Leonidou E, Chaziri I. Pulmonary Embolism in Post-CoviD-19 Patients, a Literature Review: Red Flag for Increased Awareness?. SN Compr Clin Med. 2022;4(1):190. doi:10.1007/s42399-022-01273-3 Search in Google Scholar

4 Iba T, Connors JM, Levy JH. The coagulopathy, endotheliopathy, and vasculitis of COVID-19. Inflamm Res. 2020;69(12): 1181-1189. doi:10.1007/s00011-020-01401-6 Search in Google Scholar

5 Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417-1418. doi:10.1016/S0140-6736(20)30937-5 Search in Google Scholar

6 Tang KT, Hsu BC, Chen DY. Autoimmune and Rheumatic Manifestations Associated With COVID-19 in Adults: An Updated Systematic Review. Front Immunol. 2021;12:645013. Published 2021 Mar 12. doi:10.3389/fimmu.2021.645013 Search in Google Scholar

7 Marcos-Jubilar M, Lecumberri R, Páramo JA. Immunothrombosis: Molecular Aspects and New Therapeutic Perspectives. J Clin Med. 2023;12(4):1399. Published 2023 Feb 9. doi:10.3390/jcm12041399 Search in Google Scholar

8 Niculae CM, Hristea A, Moroti R. Mechanisms of COVID-19 Associated Pulmonary Thrombosis: A Narrative Review. Biomedicines. 2023;11(3):929. Published 2023 Mar 16. doi:10.3390/biomedicines11030929 Search in Google Scholar

9 Knight R, Walker V, Ip S, et al. Association of COVID-19 With Major Arterial and Venous Thrombotic Diseases: A Population-Wide Cohort Study of 48 Million Adults in England and Wales. Circulation. 2022;146(12):892-906. doi:10.1161/CIRCULATIONAHA.122.060785 Search in Google Scholar

10 Malas MB, Naazie IN, Elsayed N, Mathlouthi A, Marmor R, Clary B. Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis. EClinicalMedicine. 2020;29:100639. doi:10.1016/j.eclinm.2020.100639 Search in Google Scholar

11 Jiménez D, García-Sanchez A, Rali P, et al. Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019: A Systematic Review and Meta-analysis. Chest. 2021;159(3):1182-1196. doi:10.1016/j.chest.2020.11.005 Search in Google Scholar

12 Tan BK, Mainbourg S, Friggeri A, et al. Arterial and venous thromboembolism in COVID-19: a study-level meta-analysis. Thorax. 2021;76(10):970-979. doi:10.1136/thoraxjnl-2020-215383 Search in Google Scholar

13 Hobohm L, Sagoschen I, Barco S, et al. COVID-19 infection and its impact on case fatality in patients with pulmonary embolism. Eur Respir J. 2023;61(1):2200619. Published 2023 Jan 27. doi:10.1183/13993003.00619-2022 Search in Google Scholar

14 Engelen MM, Vandenbriele C, Balthazar T, et al. Venous Thromboembolism in Patients Discharged after COVID-19 Hospitalization. Semin Thromb Hemost. 2021;47(4):362-371. doi:10.1055/s-0041-1727284 Search in Google Scholar

15 Scudiero F, Silverio A, Di Maio M, et al. Pulmonary embolism in COVID-19 patients: prevalence, predictors and clinical outcome. Thromb Res. 2021;198:34-39. doi:10.1016/j. thromres.2020.11.017 Search in Google Scholar

16 Roberts LN, Whyte MB, Georgiou L, et al. Postdischarge venous thromboembolism following hospital admission with COVID-19. Blood. 2020;136(11):1347-1350. doi:10.1182/blood.2020008086 Search in Google Scholar

17 Vechi HT, Maia LR, Alves MDM. Late acute pulmonary embolism after mild Coronavirus Disease 2019 (COVID-19): a case series. Rev Inst Med Trop Sao Paulo. 2020;62:e63. Published 2020 Sep 4. doi:10.1590/S1678-9946202062063 Search in Google Scholar

18 Tveita A, Hestenes S, Sporastøyl ER, et al. Pulmonary embolism in cases of COVID-19 [published correction appears in Tidsskr Nor Laegeforen. 2020 Dec 07;140(1):]. Lungeembolisme ved covid-19 [published correction appears in Tidsskr Nor Laegeforen. 2020 Dec 07;140(1):]. Tidsskr Nor Laegeforen. 2020;140(8):10.4045/tidsskr.20.0366. Published 2020 May 6. doi:10.4045/tidsskr.20.0366 Search in Google Scholar

19 Moreira BL, Santana PRP, Zanetti G, Marchiori E. COVID-19 and acute pulmonary embolism: what should be considered to indicate a computed tomography pulmonary angiography scan?. Rev Soc Bras Med Trop. 2020;53:e20200267. doi:10.1590/0037-8682-0267-2020 Search in Google Scholar

20 Vitali C, Minniti A, Caporali R, Del Papa N. Occurrence of pulmonary embolism in a patient with mild clinical expression of COVID-19. Thromb Res. 2020;192:21-22. doi:10.1016/j. thromres.2020.05.00 Search in Google Scholar

21 Joseph JW, Roberts JC, Weaver CN, Anderson JS, Wong ML. Patients with Mild COVID-19 Symptoms and Coincident Pulmonary Embolism: A Case Series. Clin Pract Cases Emerg Med. 2020;4(3):295-298. doi:10.5811/cpcem.2020.7.48254 Search in Google Scholar

22 Elkattawy S, Alyacoub R, Singh KS, Fichadiya H, Kessler W. Prothrombin G20210A Gene Mutation-Induced Recurrent Deep Vein Thrombosis and Pulmonary Embolism: Case Report and Literature Review. J Investig Med High Impact Case Rep. 2022;10:23247096211058486. doi:10.1177/23247096211058486 Search in Google Scholar

23 Lupi-Herrera E, Soto-López ME, Lugo-Dimas AJ, et al. Polymorphisms C677T and A1298C of MTHFR Gene: Homocysteine Levels and Prothrombotic Biomarkers in Coronary and Pulmonary Thromboembolic Disease. Clin Appl Thromb Hemost. 2019;25:1076029618780344. doi:10.1177/1076029618780344 Search in Google Scholar

24 Ivanova NG. Acute Myocardial Infarction, Subclavian Vein Thrombosis, and Pulmonary Embolism Secondary to COVID-19-A Case Report. Medicina (Kaunas). 2023 Mar 26;59(4):656. doi: 10.3390/medicina59040656. PMID: 37109614; PMCID: PMC10146950. Search in Google Scholar

25 Mumoli N, Dentali F, Conte G, et al. Upper extremity deep vein thrombosis in COVID-19: Incidence and correlated risk factors in a cohort of non-ICU patients. PLoS One. 2022;17(1):e0262522. Published 2022 Jan 12. doi:10.1371/journal.pone.0262522 Search in Google Scholar

26 Hasegawa T, Yazaki Y. Unusual Site of Deep Vein Thrombosis After mRNA Coronavirus Disease-2019 (COVID-19) Vaccination. Circ J. 2022;86(4):723. doi:10.1253/circj.CJ-21-0882 Search in Google Scholar

27 Kang J. Unusual arm vein thrombosis after the Moderna (mRNA-1273) COVID-19 vaccination-a case report. Ann Palliat Med. 2022;11(11):3567-3570. doi:10.21037/apm-22-343 Search in Google Scholar

28 Gonzalez S, Levine DM. Upper extremity deep venous thrombosis after BNT162b2 mRNA COVID-19 vaccine case report. Clin Case Rep. 2023;11(2):e6012. Published 2023 Feb 27. doi:10.1002/ccr3.6012 Search in Google Scholar

29 Hippisley-Cox J, Patone M, Mei XW, et al. Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARSCoV-2 positive testing: self-controlled case series study. BMJ. 2021;374:n1931. Published 2021 Aug 26. doi:10.1136/bmj.n1931 Search in Google Scholar

30 Patrizio A, Ferrari SM, Antonelli A, Fallahi P. A case of Graves’ disease and type 1 diabetes mellitus following SARS-CoV-2 vaccination. J Autoimmun. 2021;125:102738. doi:10.1016/j.jaut.2021.102738 Search in Google Scholar

31 Chen Y, Xu Z, Wang P, et al. New-onset autoimmune phenomena post-COVID-19 vaccination. Immunology. 2022;165(4):386-401. doi:10.1111/imm.13443 Search in Google Scholar

32 Patrizio A, Ferrari SM, Antonelli A, Fallahi P. A case of Graves’ disease and type 1 diabetes mellitus following SARS-CoV-2 vaccination. J Autoimmun. 2021;125:102738. doi:10.1016/j. jaut.2021.102738 Search in Google Scholar

33 Al-Beltagi M, Saeed NK, Bediwy AS. COVID-19 disease and autoimmune disorders: A mutual pathway. World J Methodol. 2022;12(4):200-223. Published 2022 Jul 20. doi:10.5662/wjm. v12.i4.200 Search in Google Scholar

34 Chen K, Gao Y, Li J. New-onset and relapsed Graves’ disease following COVID-19 vaccination: a comprehensive review of reported cases. Eur J Med Res. 2023;28(1):232. Published 2023 Jul 13. doi:10.1186/s40001-023-01210-7 Search in Google Scholar

35 Vera-Lastra O, Ordinola Navarro A, Cruz Domiguez MP, Medina G, Sánchez Valadez TI, Jara LJ. Two Cases of Graves’ Disease Following SARS-CoV-2 Vaccination: An Autoimmune/Inflammatory Syndrome Induced by Adjuvants. Thyroid. 2021;31(9):1436-1439. doi:10.1089/thy.2021.0142 Search in Google Scholar

36 Takedani K, Notsu M, Ishiai N, Asami Y, Uchida K, Kanasaki K. Graves’ disease after exposure to the SARS-CoV-2 vaccine: a case report and review of the literature. BMC Endocr Disord. 2023;23(1):132. Published 2023 Jun 15.doi:10.1186/s12902-023-01387-2 Search in Google Scholar

37 Triantafyllidis KK, Giannos P, Stathi D, Kechagias KS. Graves’ disease following vaccination against SARS-CoV-2: A systematic review of the reported cases. Front Endocrinol (Lausanne). 2022;13:938001. Published 2022 Sep 27. doi:10.3389/fendo.2022.938001 Search in Google Scholar

38 Zettinig G, Krebs M. Two further cases of Graves’ disease following SARS-Cov-2 vaccination. J Endocrinol Invest. 2022;45(1):227-228. doi:10.1007/s40618-021-01650-0 Search in Google Scholar

39 Weintraub MA, Ameer B, Sinha Gregory N. Graves Disease Following the SARS-CoV-2 Vaccine: Case Series. J Investig Med High Impact Case Rep. 2021;9:23247096211063356. doi:10.1177/23247096211063356 Search in Google Scholar

40 Singh G, Howland T. Graves’ Disease Following COVID-19 Vaccination. Cureus. 2022;14(4):e24418. Published 2022 Apr 23. doi:10.7759/cureus.24418 Search in Google Scholar

41 Sriphrapradang C, Shantavasinkul PC. Graves’ disease following SARS-CoV-2 vaccination. Endocrine. 2021;74(3):473-474. doi:10.1007/s12020-021-02902-y Search in Google Scholar

42 Pierman G, Delgrange E, Jonas C. Recurrence of Graves’ Disease (a Th1-type Cytokine Disease) Following SARS-CoV-2 mRNA Vaccine Administration: A Simple Coincidence?. Eur J Case Rep Intern Med. 2021;8(9):002807. Published 2021 Sep 2. doi:10.12890/2021_002807 Search in Google Scholar

43 Vojdani A, Vojdani E, Kharrazian D. Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases. Front Immunol. 2021;11:617089. Published 2021 Jan 19. doi:10.3389/fimmu.2020.617089 Search in Google Scholar